Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
33
XYL Quote, Financials, Valuation and Earnings
Last price:
$138.70
Seasonality move
:
2.47%
Day range:
$138.42 - $139.12
52-week range:
$100.47 - $154.27
Dividend yield:
1.15%
P/E ratio:
35.66x
P/S ratio:
3.80x
P/B ratio:
3.01x
Volume:
683.2K
Avg. volume:
1.5M
1-year change:
17.42%
Market cap:
$33.7B
Revenue:
$8.6B
EPS (TTM):
$3.89
Analysts' Opinion
-
Consensus RatingXylem, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $167.41, Xylem, Inc. has an estimated upside of 20.77% from its current price of $138.73.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $129.00 representing 100% downside risk from its current price of $138.73.
Fair Value
-
According to the consensus of 18 analysts, Xylem, Inc. has 20.77% upside to fair value with a price target of $167.41 per share.
XYL vs. S&P 500
-
Over the past 5 trading days, Xylem, Inc. has underperformed the S&P 500 by -1.23% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Xylem, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Xylem, Inc. has grown year-over-year revenues for 15 quarters straight. In the most recent quarter Xylem, Inc. reported revenues of $2.3B.
Earnings Growth
-
Xylem, Inc. has grown year-over-year earnings for 9 quarters straight. In the most recent quarter Xylem, Inc. reported earnings per share of $0.93.
Enterprise value:
34.9B
EV / Invested capital:
2.58x
Price / LTM sales:
3.80x
EV / EBIT:
28.45x
EV / Revenue:
3.92x
PEG ratio (5yr expected):
2.60x
EV / Free cash flow:
37.71x
Price / Operating cash flow:
36.55x
Enterprise value / EBITDA:
19.38x
Gross Profit (TTM):
$3.4B
Return On Assets:
5.64%
Net Income Margin (TTM):
10.61%
Return On Equity:
8.53%
Return On Invested Capital:
7.13%
Operating Margin:
15.54%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $6.8B | $8.4B | $8.9B | $2.1B | $2.3B | |
| Gross Profit | $2.5B | $3.1B | $3.4B | $784M | $878M | |
| Operating Income | $659M | $1B | $1.2B | $284M | $352M | |
| EBITDA | $1B | $1.6B | $1.8B | $425M | $494M | |
| Diluted EPS | $2.44 | $3.42 | $3.89 | $0.89 | $0.93 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.1B | $3.2B | $3.7B | $4B | $4.4B | |
| Total Assets | $8.2B | $8.1B | $15.9B | $16B | $17.3B | |
| Current Liabilities | $1.3B | $1.9B | $2.1B | $2.1B | $2.3B | |
| Total Liabilities | $5B | $4.9B | $6B | $5.4B | $5.9B | |
| Total Equity | $3.1B | $3.2B | $9.9B | $10.6B | $11.4B | |
| Total Debt | $2.5B | $1.9B | $2.3B | $2B | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $744M | $1.1B | $1.3B | $311M | $360M | |
| Cash From Investing | -$607M | -$282M | -$618M | -$65M | -$189M | |
| Cash From Financing | -$651M | -$606M | -$477M | -$101M | -$138M | |
| Free Cash Flow | $507M | $828M | $925M | $237M | $281M | |
XYL
Sector
Market Cap
$33.7B
$486.6M
Price % of 52-Week High
89.86%
80.87%
Dividend Yield
1.15%
0%
Shareholder Yield
1.07%
1.54%
1-Year Price Total Return
17.96%
--
Beta (5-Year)
1.176
0.550
Dividend yield:
1.15%
Annualized payout:
$1.44
Payout ratio:
43.01%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$137.99
200-day SMA
Buy
Level
$133.69
Bollinger Bands (100)
Sell
Level
139.24 - 147.54
Chaikin Money Flow
Buy
Level
368.6K
20-day SMA
Sell
Level
$138.81
Relative Strength Index (RSI14)
Sell
Level
45.27
ADX Line
Buy
Level
18.51
Williams %R
Neutral
Level
-54.9902
50-day SMA
Sell
Level
$143.55
MACD (12, 26)
Buy
Level
36.41
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
138.2K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.1434)
Buy
CA Score
(Annual)
Level (0.6719)
Buy
Beneish M-Score
(Annual)
Level (-2.5463)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-2.383)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Xylem, Inc. engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water. The Applied Water segment encompasses the uses of water and focuses on the commercial, residential, and industrial end markets. The Measurement and Control Solutions segment focuses on developing technology solutions that enable intelligent use and conservation of critical water and energy resources as well as analytical instrumentation used in the testing of water. The company was founded in 2011 and is headquartered in Washington, DC.
Stock Forecast FAQ
In the current month, XYL has received 10 Buy ratings 8 Hold ratings, and 0 Sell ratings. The XYL average analyst price target in the past 3 months is $167.41.
-
Where Will Xylem, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Xylem, Inc. share price will rise to $167.41 per share over the next 12 months.
-
What Do Analysts Say About Xylem, Inc.?
Analysts are divided on their view about Xylem, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Xylem, Inc. is a Sell and believe this share price will drop from its current level to $129.00.
-
What Is Xylem, Inc.'s Price Target?
The price target for Xylem, Inc. over the next 1-year time period is forecast to be $167.41 according to 18 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is XYL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Xylem, Inc. is a Buy. 10 of 18 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of XYL?
You can purchase shares of Xylem, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Xylem, Inc. shares.
-
What Is The Xylem, Inc. Share Price Today?
Xylem, Inc. was last trading at $138.70 per share. This represents the most recent stock quote for Xylem, Inc.. Yesterday, Xylem, Inc. closed at $138.73 per share.
-
How To Buy Xylem, Inc. Stock Online?
In order to purchase Xylem, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get XYL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
XYL
Sector
P/E ratio
35.66x
19.19x
PEG ratio
2.60x
0.18x
P/B ratio
3.01x
1.70x
Price / LTM sales
3.80x
0.85x
Growth Metrics
XYL
Sector
Revenue growth
7.7%
5.02%
Earnings growth
4.46%
5.76%
Revenue (5-year growth)
10.25%
4.27%
Earnings forecast
$1.23
$0.39
Profitability
XYL
Sector
Profitability FY 2024
$3.2B
$253.7M
Return on invested capital
7.13%
4.73%
Return on assets
5.64%
3.1%
Return on equity
8.53%
8.11%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Feb
3
Estimated Next Earnings Date
Jan
27
Balance Sheet
XYL
Sector
Total cash
$1.2B
$139M
Short term investments
--
$32.7M
Total assets
$16.5B
$1.4B
Long term debt
$1.9B
$51.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
87
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
60
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
